Researchers have found that an OPA1-targeted gene therapy can treat dominant optic atrophy in pre-clinical trials.
A model of a human lung cell has been used to understand how SARS-CoV-2 uses host cell processes to reproduce, revealing drug targets.
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals for at least six months.
Researchers have found that neutralising antibodies for the TNF-alpha and IFN-gamma cytokines can prevent death from SARS-CoV-2 in mice.
Researchers have found that CBD induces an enzyme with antioxidant and anti-inflammatory properties in the top layer of the skin.
Researchers have discovered new drug compounds that target the SKI complex of SARS-CoV-2, preventing replication.
Researchers have engineered human angiotensin converting enzyme 2 (hACE2) protein decoys that can protect cells from SARS-CoV-2.
According to a new study, the SARS-CoV-2 virus is accumulating genetic mutations, including D614G which may have made it more contagious.
Researchers have found the genome of COVID-19 and infected cell syncytia in the respiratory cells, explaining long-term coronavirus effects.
Binding of SARS-CoV-2 spike proteins to the brain’s endothelial cells could be the cause the neurological symptoms associated with COVID-19.